Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.94 -0.20 (-0.77%)
At close: Oct 20, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Net of Acquisitions & Divestments (2016)

Updated

Analysis

Amphastar Pharmaceuticals (AMPH) Net of Acquisitions & Divestments (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -8.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 17.24 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 39.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -11.21 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Amphastar Pharmaceuticals 1.13 Bn -10.28 Mn 93.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -7.70 Mn
Mar 31, 2016 -4.76 Mn
API Access

Amphastar Pharmaceuticals Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=AMPH&period=max&api_key=YOUR_API_KEY